The use of corticosteroids in severe sepsis and acute respiratory distress syndrome

References

• Waterhouse R. Case of suprarenal apoplexy. Lancet 1911; 1: 577.
   Google Scholar
• Fridetichsen C. NebennIerenapoplexie bei kleinen Kindern. Jb Kinderheilk 1918; 87: 109.
   Google Scholar
• Perla D, mannorston J. Suprarenal cortical hormone and salt in the treatment of pneumonia and other severe infections. Endocrinology 1940; 27: 367–74.
   Google Scholar
• Hahn EO, Houser HB, Rammelkamp CH, Denny FW, Wannamalcer LW. Effect of cortisone on acute streptococcal infections and post-streptococcal complications. J Clin Invest 1950; 30: 274–81.
   Google Scholar
• Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984; 311: 1137–43.
   PubMed Web of Science ®Google Scholar
• Lucas CE, Ledgerwood AM. The cardiopulmonary response to massive doses of steroids in patients with septic shock. Arch Surg 1984; 119: 537–41.
   PubMed Web of Science ®Google Scholar
• Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylpred-nisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317: 653–8.
   PubMed Web of Science ®Google Scholar
• The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317: 659–65.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al. High dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317: 1565–70.
   PubMed Web of Science ®Google Scholar
• Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988; 138: 62–8.
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991; 337: 582–3.
   PubMed Web of Science ®Google Scholar
• Annane D, Sallie V, Troche G, Raphael JC, Gajdos P, Bellissant F. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283: 1038–45.
   PubMed Web of Science ®Google Scholar
• Molijn GJ, Spek JJ, van Uffelen JC, de Jong FH, Brinkmann AO, Bruining HA, et al. Differential adaptation of gluco-corticoid sensitivity of peripheral blood mononuclear leuko-cytes in patients with sepsis or septic shock. J Clin Endocrinol Metab 1995; 80: 1799–803.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprenisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280: 159–65.
   PubMed Web of Science ®Google Scholar
• Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26: 645–50.
   PubMed Web of Science ®Google Scholar
• Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27: 723–32.
   PubMed Web of Science ®Google Scholar
• Lenczowski MJ, Schmidt ED, Van Dam AM, Gaykema RP, Tilders F J. Individual variation in hypothalamus-pituitary-adrenal responsiveness of rats to endotoxin and interleukin-1 beta. Ann N Y Acad Sci 1998; 856: 139–47.
   PubMedGoogle Scholar
• McCann SM, Karanth S, Kamat A, Les Dees W, Lyson K, Gimeno M, et al. Induction by cytokines of the pattern of pituitary hormone secretion in infection. Neuroimmunomodu-lation 1994; 1: 2–13.
   PubMedGoogle Scholar
• Wong ML, Rettori V, Shekhlee A, Bongiorno PB, Canteros G, McCann SM, et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med 1996; 2: 581–4.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Hernandez JA, Bornstein SR, Ehrhart-Bornstein M, Spath-Schwalbe E, Jirikowski G, Scherbaum WA. Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function. J Clin Endocrinol Metab 1994; 79: 1492–7.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Spathsch-walbe E, Scherbaum WA, Bornstein SR. Human adrenal cells express tumor necrosis factor-alpha messenger ribonucleic acid - evidence for paracrine control of adrenal function. J Clin Endocrinol Metab 1996; 81: 807–13.
   PubMedGoogle Scholar
• Path G, Bornstein SR, Spathschwalbe E, Scherbaum WA. Direct effects of interleukin-6 on human adrenal cells. Endocr Res 1996; 22: 867–73.
   PubMed Web of Science ®Google Scholar
• Darling G, Goldstein DS, Stull R, Gorschboth CM, Norton JA. Tumor necrosis factor: immune endocrine interaction. Surgery 1989; 106: 1155–60.
   PubMed Web of Science ®Google Scholar
• Gaykema RP, Dijkstra I, Tilders FJ Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypo-thalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology 1995; 136: 4717–20.
   PubMedGoogle Scholar
• Ballard PL, Baxter JD, Higgins SJ, Rousseau GC, Tomkins GM. General presence of glucocorticoid receptors in mam-malian tissues. Endocrinology 1974; 94: 998–1002.
   PubMed Web of Science ®Google Scholar
• Beat° M. Gene regulation by steroid hormones. Cell 1989; 56: 335–44.
   PubMedGoogle Scholar
• Knudsen PJ, Dinarello CA, Strom TB. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 1987; 139: 4129–34.
   PubMed Web of Science ®Google Scholar
• Ray A, Prefontaine KE. Physical Association and Functional Antagonism Between the p65 Subunit of Transcription Factor NF-kappa B and the Glucocorticoid Receptor. Proc Natl Acad Sci USA 1994; 91: 752–6.
   PubMed Web of Science ®Google Scholar
• Scheinman RI, Cogswell PC, Lofquist AK, Baldwin Jr AS. Role of transcriptional activation of IKBa in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283–6.
   PubMed Web of Science ®Google Scholar
• Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Inununosuppression by glucocorticoids: inhibition of NE-KB activity through induction of IKB synthesis. Science 1995; 270: 286–90.
   PubMed Web of Science ®Google Scholar
• Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (I1)-10 inhibits nuclear factor kappa B (NF-kappa B) activation in human monocytes: I1-10 and 11-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995; 270: 9558–63.
   PubMed Web of Science ®Google Scholar
• Hofmann TG, Hehner SP, Bacher S, Droge W, Schmitz ML. Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress nuclear factor-kappa-B dependent transcription. FEBS Lett 1998; 441: 441–6.
   PubMedGoogle Scholar
• Chrousos GP. The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture. Ann N Y Acad Sci 2000; 917: 38–67.
   PubMed Web of Science ®Google Scholar
• Tobian L. Interrelationship of electrolytes, juxtaglomerular cells and hypertension. Physiol Rev 1960; 40: 280–312.
   PubMedGoogle Scholar
• Grunfeld JP, Eloy L. Glucocorticoids modulate vascular reactivity in the rat. Hypertension 1987; 10: 608–18.
   PubMed Web of Science ®Google Scholar
• McKenzie AW, Stoughton Rfl. Method for comparing percutaneous absorption of steroids. Archs Derm 1962; 86: 608–10.
   Web of Science ®Google Scholar
• Yard AC, Kadowitz P J. Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal. Eur J Pharmacol 1972; 20: 1–9.
   PubMedGoogle Scholar
• Kelly JJ, Mangos G, Williamson PM, Whitworth JA. Cortisol and hypertension. Clin Exp Pharmacol Physiol Suppl 1998; 25: S51–6.
   PubMedGoogle Scholar
• Thiemermann C, Vane JR. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysacchar-ides in the rat in vivo. Eur J Pharmacol 1990; 182: 591–5.
   PubMed Web of Science ®Google Scholar
• Paya D, Gray GA, Fleming I, Stodet JC. Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. coli lipopolysaccharide in rats. Circ Shock 1993; 41: 103–12.
   PubMedGoogle Scholar
• May ME, Vaughan ED, Carey RM. Adrenocortical insufficiency - clinical aspects. In: Vaughan ED Jr, Carey RM, eds. Adrenal disorders. New York: Thieme Medical; 1989: 171–89.
   Google Scholar
• Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (1 µg) adrebnocorticotropin test in the evaluation of patients with pituitary disease. J Clin Endocrinol Metab 1995; 80: 1301–5.
   PubMed Web of Science ®Google Scholar
• Koo DJ, Jackman D, Chaudry IH, Wang P. Adrenal insufficiency during the late stage of polymicrobial sepsis. Crit Care Med 2001; 29: 618–22.
   PubMed Web of Science ®Google Scholar
• Tayek JA, Atienza VJ. Pituitary adrenal axis function in systemic inflammatory response syndrome. Endocrine 1995; 3: 1055–9.
   Google Scholar
• Annane D, Bellissant E, Sebille V, Lesieur O, Mathieu B, Raphael JC, et al. Impaired pressor sensitivity to noradrena-line in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998; 46: 589–97.
   PubMed Web of Science ®Google Scholar
• Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001; 27: 1584–91.
   PubMed Web of Science ®Google Scholar
• Rook G, Baker R, Walker B, Honour J, Jessop D, Hemadez-Pando R, et al. Local regulation of glucocorticoid activity in sites of inflammation: insights from the study of tuberculosis. Ann N Y Acad Sci 2000; 917: 913–22.
   PubMedGoogle Scholar
• Almawi WY, Lipman ML, Stevens AC, Zanker B, Hadro ET, Strom Tfl. Abrogation of glucocorticoid-mediated in-hibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. J Immunol 1991; 146: 3523–7.
   PubMed Web of Science ®Google Scholar
• Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY. Combination of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993; 151: 3460–6.
   PubMed Web of Science ®Google Scholar
• Molijn GJ, Koper JW, van Uffelen CJ, de Jong FH, Brinkmaim AO, Bruining HA, et al. Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock. Clin Endocrinol 1995; 43: 197–203.
   PubMedGoogle Scholar
• Barber AE, Coyle SM, Fischer E, Smith C, van der Poll T, Shires GT et al. Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery 1995; 118: 406–10.
   PubMedGoogle Scholar
• van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin-10 concentra-tions during human endotoxemia - a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3604–6.
   Google Scholar
• Briegel J, Kellermann W, Forst H, Haller M, Bittl M, Hoffmann GE, et al. Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The phospholipase A2 study group. Clin Investig 1994; 72: 782–7.
   PubMedGoogle Scholar
• Key D. Effects of hydrocortisone on the immune response in patients with septic shock - results from a double-blind cross-over study. J Anasth Intens 1999; 1: S195–6.
   Google Scholar
• Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 1998; 158: 1432–41.
   Google Scholar
• van Leeuwen HJ, van der Bruggen T, van Asbeck S, Bo ereboom FT J. Effects of corticosteroids on nuclear factor - kB activation and hemodynamics in late septic shock. Crit Care Med 2001; 29: 1074–7.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflamma-tion in patients with unresolving acute respiratory distress syndrome and in response: evidence for inadequate endogen-ous glucocorticoid secretion and inflammation-induced im-mune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002; 165: 983–91.
   PubMed Web of Science ®Google Scholar
• Szabo C, Thiemennann C, Wu CC, Perretti M, Vane JR. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 1994; 91: 271–5.
   PubMed Web of Science ®Google Scholar
• Bhagat K, Collier J, Valance B. Local venous responses to endotoxin in humans. Circulation 1996; 94: 490–7.
   PubMedGoogle Scholar
• Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993; 150: 1999–2006.
   PubMed Web of Science ®Google Scholar
• Bellissant E, Annane D. Effect of hydrocortisone on phenylephrine - mean arterial pressure dose - response relationship in septic shock. Clin Pharmacol Ther 2000; 68: 293–303.
   PubMed Web of Science ®Google Scholar
• Chawla K, Kupfer y, Tessler S. Hydrocortisone reverses refractory septic shock. Crit Care Med 1999; 27: A33.
   Web of Science ®Google Scholar
• Annane D, Sébille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of a 7-Day Treatment with Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients with Septic Shock. JAMA (in press).
   Google Scholar
• McKee JI, Finlay WEI. Cortisol replacement in severely stressed patients. Lancet 1983; 1: 284.
   PubMedGoogle Scholar
• Ashbaugh DG, Maier RV. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment. Arch Surg 1985; 120: 530–5.
   PubMedGoogle Scholar
• Hooper RG, Kearl RA. Established ARDS treated with sustained course of adrenocortical steroids. Chest 1990; 97: 138–43.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, El Torky M, Leeper KV Jr. Fibroprolderative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 1991; 100: 943–52.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Chinn AJ, Leeper KV Jr, Wunderink RG, Tolley E, Winer-Muram HT, et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Pattern of response and predictors of outcome. Chest 1994; 105: 1516–27.
   PubMed Web of Science ®Google Scholar
• Biffl WL, Moore FA, Moore EE, Haenel JB, Mc Intyre RC Jr, Burch JM. Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome? Am J Surg 1995; 170: 591–6.
   PubMedGoogle Scholar
• Hooper RG, Kearl RA. Established adult respiratory distress syndrome successfully treated with corticosteroids. South Med J 1996; 89: 359–64.
   PubMed Web of Science ®Google Scholar
• Keel JBP, Hauser M, Stocker R, Baumann PC, Speich R. Established acute respiratory distress syndrome: benefit of corticosteroid rescue therapy. Respiration 1998; 65: 258–64.
   PubMedGoogle Scholar
• Yildiz O, Doganey M, Aygen B, Giiven M, Kelestimur F, Tutus A. Physiological dose steroid therapy in sepsis. Crit Care 2002; 6: 251–8.
   PubMedGoogle Scholar